Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Capitol Hill In Brief

This article was originally published in The Tan Sheet

Executive Summary

Congress passes CR with cuts to FDA

You may also be interested in...



Hearing Targets Health Account OTC Issue As Reform Law Proxy

Republicans on the Subcommittee on Oversight oppose the provision in health care reform requiring consumers to have a prescription to purchase OTCs with pre-tax savings account funds. Democrats argue the revenue is needed to pay for health care reform and lower costs for everyone.

Hearing Targets Health Account OTC Issue As Reform Law Proxy

Republicans on the Subcommittee on Oversight oppose the provision in health care reform requiring consumers to have a prescription to purchase OTCs with pre-tax savings account funds. Democrats argue the revenue is needed to pay for health care reform and lower costs for everyone.

Hearing Targets Health Account OTC Issue As Reform Law Proxy

Republicans on the Subcommittee on Oversight oppose the provision in health care reform requiring consumers to have a prescription to purchase OTCs with pre-tax savings account funds. Democrats argue the revenue is needed to pay for health care reform and lower costs for everyone.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel